Be a part of our medical cannabis research study!

Om Research

These are for the buttons and the associated content off the medical research page.

ASSESSING EXPERIENCES OF MEDICAL CANNABIS PATIENTS (ENROLLING NOW!)
ASSESSING EXPERIENCES OF MEDICAL CANNABIS PATIENTS (ENROLLING NOW!) 150 150 omie

Our 3rd IRB-approved study is in collaboration with Dr. Dan Kruger, an University of Michigan public health professor! It is titled: Assessing and Monitoring the experiences of medical cannabis users.

The purpose of this study is to examine the real-life experiences of medical cannabis patients to help provide valuable information for existing practices and public policy.

Participation Eligibility:

  1. Age requirement- 18 years and older
  2. State issued Medical Cannabis Patient Cardholder

Participating in this study is completely voluntary. Even if you decide to participate now, you may change your mind and stop at any time. You may choose not to complete the survey or answer questions for any reason.

Click here for the link to the survey!

On average, this survey may take up 15-20 minutes to complete. Please prepare to answer questions about your knowledge related to the medical use of cannabis, your patterns of use and routes of administration, your experiences with health care professionals regarding medical cannabis and comparisons between cannabis pharmaceutical drugs.

2019 Nationwide Chronic Pain Study
2019 Nationwide Chronic Pain Study 150 150 omie

We partnered again with the University of Michigan for our second research study in 2018, titled: “Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain.”

By widening our reach from only Michigan patients to cardholders across many medical states, we are able to further implicate our findings on larger, more encompassing level.

Our goal is to further examine how cannabis use is related to pain management, quality of life, and the use of other medications. We can use the information collected to not only help our patients directly but help inform physicians, researchers, policy-makers about the potential benefits and risk of cannabis as a therapeutic agent.

We are currently in the process of being published! Stay tuned for our results and major findings.

2016 Michigan Chronic Pain Study
2016 Michigan Chronic Pain Study 150 150 admin

In collaboration with the University of Michigan, we published our first IRB-approved study in the Journal of Pain.

Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain (2016)

We conducted a survey of 244 medical cannabis patients in Michigan with chronic pain for 3 months. Our goal was to collect data to examine if  using medical cannabis for chronic pain affected one’s opioid consumption as well. We saw testimonial evidence of this everyday in our consultation rooms.

Three Major Conclusions: 
  1. Cannabis use was associated with 64% lower opioid use in patients with chronic pain.
  2. Cannabis use was associated with 45% better quality of life in patients with chronic pain.
  3. Cannabis use was associated with fewer medication side effects and medications used.
Impact Since Published:  

After publication in 2016, our study has been cited in several important reports including